Alexandra Welschmeyer

Alexandra Welschmeyer

Auto-generated profile, based on publicly available information

Alexandra Welschmeyer

Department of Otolaryngology ‐ Head and Neck Surgery University Hospitals Cleveland Medical Center Cleveland Ohio USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2020 in Neurology International
Verified
Journal Article
Open access
PDF file
ABAmnon Berger
Amnon Berger
AWAriel Winnick
Ariel Winnick
AWAlexandra Welschmeyer
Alexandra Welschmeyer
AKAlicia Kaneb
Alicia Kaneb
KBKevin Berardino
Kevin Berardino
IUIvan Urits
Ivan Urits
Parkinson’s disease (PD) is a common neurodegenerative disorder that leads to significant morbidity and disability. PD is caused by a loss of dopaminergic, cholinergic, serotonergic, and noradrenergic neurons in the central nervous system (CNS), and peripherally; the syndromic parkinsonism symptoms of movement disorder, gait disorder, rigidity and tremor are mostly driven by the loss of these neurons in the basal ganglia. Unfortunately, a significant proportion of patients taking levodopa, the standard of care treatment for PD, will begin to experience a decrease in effectiveness at varying times. These periods, referred to as “off episodes”, are characterized by increased symptoms and have a detrimental effect on quality of life and disability. Istradefylline, a novel adenosine A2A receptor antagonist, is indicated as a treatment addition to levodopa/carbidopa in patients experiencing “off episodes”. It promotes dopaminergic activity by antagonizing adenosine in the basal ganglia. This review will discuss istradefylline as a treatment for PD patients with off episodes.

28 January 2021 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
AWAlexandra Welschmeyer
Alexandra Welschmeyer
GBGerald S. Berke
Gerald S. Berke
Objectives: To identify studies evaluating the epidemiology of recurrent respiratory papillomatosis (RRP), including patient demographics, human papillomavirus (HPV) immunology, clinical course, surgical and medical treatments, and psychosocial factors.Methods: A systematic literature search through PubMed was performed to identify studies evaluating the epidemiological factors associated with RRP. All studies were screened through a priori selection criteria using the titles and abstracts.Results: A total of 208 studies were identified, of which 54 met eligibility criteria and were included in the review.Conclusions: RRP is a rare disease most commonly caused by HPV 6 and 11. It is characterized by recurring benign papillomatous lesions in the respiratory tract, particularly the larynx. Existing evidence about disease risk factors is limited but includes both maternal HPV infection and patient smoking and sexual behaviors. Disease management involves a combination of routine surgical and medical treatment. Surgical techniques include CO2‐laser, sharp dissection, coblation, microdebridement, and photoangiolytic laser. Medical treatments which have been found to facilitate disease control off‐label include interferon‐alpha (IFN‐α), indole‐3‐carbinol, acyclovir, bevacizumab, retinoids, and the Gardasil and mumps vaccines. Many patients suffer from additional psychosocial challenges related to their diagnosis. Current disease knowledge remains limited, and more robust controlled trials about risk factors, medical therapies, and surgical options are needed.Level of Evidence: 5.

17 March 2021 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
ABAmnon Berger
Amnon Berger
YLYao Liu
Yao Liu
KJKevin Jin
Kevin Jin
AKAlicia Kaneb
Alicia Kaneb
AWAlexandra Welschmeyer
Alexandra Welschmeyer
IUIvan Urits
Ivan Urits
Context: Abdominal pain is a widespread complaint and is one of the common reasons leading patients to seek medical care, either in emergency situations or with their primary providers. While acute abdominal pain is a better defined, usually surgical condition, chronic abdominal pain requires longer, typically lifelong, therapy. Chronic abdominal pain may also present with acute flares and complications. Here we review seminal and novel evidence discussing the use of acupuncture in the treatment of abdominal pain, indications, and conditions that may benefit from this approach. Evidence Acquisition: Chronic abdominal pain is a common complaint causing significant morbidity and disability and has a hefty price tag attached. Recent studies show it may be prevalent in as much as 25% of the adult population. It is defined as three episodes of severe abdominal pain over the course of three months. Chronic abdominal pain could be the result of chronicity of acute pain or of chronic pain syndromes, most commonly IBD syndromes and IBS. While a plethora of treatments exists for both conditions, these treatments usually fall short of complete symptom control, and there is a need for complementary measures to curb disability and increase the quality of life in these patients. Acupuncture is a form of integrative medicine that has long been used in Chinese and traditional medicine, based on the rebalancing of the patient’s Qi, or Ying/Yang balance. It has been shown to be effective in treating several other conditions, and novel evidence may expand its use into other fields as well. Clinical trials studying acupuncture in chronic pain conditions have been promising, and recent evidence supports the use of abdominal pain in chronic abdominal pain conditions as well. Though not curative, acupuncture is a complementary approach that helps reduce symptoms and improved quality of life. Conclusions: Chronic abdominal pain is a widespread condition, mostly affected by the IBS and IBD spectrum. Etiologies are still being studied for these conditions, and while novel treatment approaches are absolute game changers for these patients, many continue to experience some level of symptoms and disability. Acupuncture may provide further alleviation of these symptoms in select patients, thus improving quality of life, reducing disability, and saving healthcare dollars. It is a largely safe and inexpensive method that may significantly contribute to the quality of life of selected patients.

1 November 2022 in Journal of Surgical Education
Verified
Journal Article
Closed access
JHJamil Hayden
Jamil Hayden
RHRandall J. Harley
Randall J. Harley
NDNikita Deshpande
Nikita Deshpande
DSDaniel Swanson
Daniel Swanson
AWAlexandra Welschmeyer
Alexandra Welschmeyer
EHEarl H. Harley
Earl H. Harley

27 August 2024 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
AWAlexandra Welschmeyer
Alexandra Welschmeyer
MKMaxwell Kligerman
Maxwell Kligerman
JNJulia Noel
Julia Noel
Objective: Optimal management of indeterminate nodules remains a controversial area of endocrine surgery. The purpose of this study is to compare observation, molecular testing, and immediate thyroid surgery for the management of Bethesda Classes III and IV nodules in patients age 50 to 90 years. Study Design: A decision analysis was performed from April 22, 2021, to September 29, 2023, using a Markov model constructed with TreeAgePro 2023. Model variables and ranges were selected based on literature review data. Setting: TreeAgePro. Methods: A 1‐way sensitivity analysis was performed to evaluate the age threshold at which each management pathway, immediate thyroid surgery, additional molecular testing, or observation, would be favored. A Monte Carlo probabilistic sensitivity analysis was performed 5 times with model patients assigned starting ages of 50, 60, 70, 80, and 90 years to assess how age at diagnosis would impact model results. Outcomes were measured with quality‐adjusted life‐years and accounted for perioperative complications including permanent recurrent laryngeal nerve injury, permanent hypoparathyroidism, and medical complications. Results: In the study models, molecular testing was more beneficial than surgery and observation across all ages. The age threshold at which observation became more beneficial than surgery as the next best option was 83.1 years. However, the clinical difference between all 3 treatment algorithms was relatively minimal. Conclusions: Decision‐making regarding indeterminate thyroid nodules is complex. Given the clinically similar results across all 3 treatment algorithm, this study reinforces that treatment modalities should be individually tailored and based on shared physician‐patient decision making.

22 February 2025 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
DKDaniel Karasik
Daniel Karasik
AGAmanda M. Goslawski
Amanda M. Goslawski
ETEve Tranchito
Eve Tranchito
AWAlexandra F. Welschmeyer
Alexandra F. Welschmeyer
CCClaudia I. Cabrera
Claudia I. Cabrera
CRCyrus Rabbani
Cyrus Rabbani